TEL REVELOL 40/50

About

TEL REVELOL 40/50 is a fixed-dose combination medication containing Telmisartan 40 mg and Metoprolol Succinate 50 mg (extended-release). This combination is prescribed for the management of essential hypertension, particularly when monotherapy with either agent is insufficient to achieve target blood pressure. Telmisartan, an angiotensin II receptor blocker (ARB), works by relaxing blood vessels, while Metoprolol, a cardioselective beta-blocker, slows the heart rate and reduces the heart's workload. By targeting multiple pathways involved in blood pressure regulation, this combination provides a comprehensive and potent approach to blood pressure control, reducing the risk of cardiovascular events such as stroke and heart attack.

Uses

• Treatment of essential hypertension
• Management of high blood pressure
• Reduction of cardiovascular risk
• Adjunctive therapy for angina pectoris

Directions For Use

Take orally once daily, preferably with food, as directed by your physician. Swallow the tablet whole; do not crush or chew.Benefits

• Potent blood pressure reduction
• Dual mechanism of action for comprehensive control
• Reduces overall cardiovascular risk
• Improves symptoms of angina pectoris
• Provides sustained blood pressure control
• Convenient single-pill regimen

Side Effects

• Dizziness
• Fatigue
• Bradycardia
• Hypotension
• Nausea
• Diarrhea
• Headache
• Cough
• Shortness of breath
• Cold extremities
• Hyperkalemia
• Depression

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can significantly increase hypotensive effects and dizziness.
• Pregnancy - Contraindicated in the second and third trimesters due to Telmisartan's risk of fetal injury. Discontinue immediately if pregnancy is detected.
• Breastfeeding - Not recommended due to potential adverse effects on the infant from Telmisartan; an alternative should be considered.
• Liver - Use with caution in patients with severe hepatic impairment; dosage adjustment may be necessary due to altered metabolism of both components.
• Kidney - Use with caution in patients with renal artery stenosis or severe renal impairment; monitor kidney function closely.
• Lung - Contraindicated in severe bronchial asthma or severe COPD due to the Metoprolol component. Use with extreme caution in mild to moderate cases.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.